These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2427933)

  • 1. A mechanism for the insertion of complement component C9 into target membranes.
    Stanley KK; Page M; Campbell AK; Luzio JP
    Mol Immunol; 1986 May; 23(5):451-8. PubMed ID: 2427933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topological mapping of complement component C9 by recombinant DNA techniques suggests a novel mechanism for its insertion into target membranes.
    Stanley KK; Herz J
    EMBO J; 1987 Jul; 6(7):1951-7. PubMed ID: 2443347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formation of transmembrane tubules by spontaneous polymerization of the hydrophilic complement protein C9.
    Tschopp J; Müller-Eberhard HJ; Podack ER
    Nature; 1982 Aug; 298(5874):534-8. PubMed ID: 7099251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement C9 is inserted into membranes in a globular conformation.
    Marazziti D; Luzio JP; Stanley KK
    FEBS Lett; 1989 Jan; 243(2):347-50. PubMed ID: 2917655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigenic crossreactivity of the alpha subunit of complement component C8 with the cysteine-rich domain shared by complement component C9 and low density lipoprotein receptor.
    Tschopp J; Mollnes TE
    Proc Natl Acad Sci U S A; 1986 Jun; 83(12):4223-7. PubMed ID: 2424021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topology of the membrane-bound form of complement protein C9 probed by glycosylation mapping, anti-peptide antibody binding, and disulfide modification.
    Rossi V; Wang Y; Esser AF
    Mol Immunol; 2010 Apr; 47(7-8):1553-60. PubMed ID: 20153530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The architectural transition of human complement component C9 to poly(C9).
    DiScipio RG; Berlin C
    Mol Immunol; 1999 Jun; 36(9):575-85. PubMed ID: 10499811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of C5b-8 binding sites in the C9 molecule using monoclonal antibodies: participation of two separate epitopes of C9 in C5b-8 binding.
    Hatanaka M; Seya T; Yoden A; Fukamoto K; Semba T; Inai S
    Mol Immunol; 1992; 29(7-8):911-6. PubMed ID: 1378934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitronectin-mediated inhibition of complement: evidence for different binding sites for C5b-7 and C9.
    Milis L; Morris CA; Sheehan MC; Charlesworth JA; Pussell BA
    Clin Exp Immunol; 1993 Apr; 92(1):114-9. PubMed ID: 7682159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of refolding conformers of complement protein C9 during insertion into membranes.
    Laine RO; Esser AF
    Nature; 1989 Sep; 341(6237):63-5. PubMed ID: 2475785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Killing of gram-negative bacteria by complement. Fractionation of cell membranes after complement C5b-9 deposition on to the surface of Salmonella minnesota Re595.
    Tomlinson S; Taylor PW; Morgan BP; Luzio JP
    Biochem J; 1989 Oct; 263(2):505-11. PubMed ID: 2597121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A synthetic peptide from complement protein C9 binds to CD59 and enhances lysis of human erythrocytes by C5b-9.
    Tomlinson S; Whitlow MB; Nussenzweig V
    J Immunol; 1994 Feb; 152(4):1927-34. PubMed ID: 7509832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of homologous complement by CD59 is mediated by a species-selective recognition conferred through binding to C8 within C5b-8 or C9 within C5b-9.
    Rollins SA; Zhao J; Ninomiya H; Sims PJ
    J Immunol; 1991 Apr; 146(7):2345-51. PubMed ID: 1706395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Species-restricted target cell lysis by human complement: complement-lysed erythrocytes from heterologous and homologous species differ in their ratio of bound to inserted C9.
    Hu VW; Shin ML
    J Immunol; 1984 Oct; 133(4):2133-7. PubMed ID: 6470486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The molecular mechanism of complement C9 insertion and polymerisation in biological membranes.
    Stanley KK
    Curr Top Microbiol Immunol; 1989; 140():49-65. PubMed ID: 2644075
    [No Abstract]   [Full Text] [Related]  

  • 16. The membrane attack complex of complement: lipid insertion of tubular and nontubular polymerized C9.
    Amiguet P; Brunner J; Tschopp J
    Biochemistry; 1985 Dec; 24(25):7328-34. PubMed ID: 4084584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations in the putative lipid-interaction domain of complement C9 result in defective secretion of the functional protein.
    Dupuis M; Peitsch MC; Hamann U; Stanley KK; Tschopp J
    Mol Immunol; 1993 Jan; 30(1):95-100. PubMed ID: 8417379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of complement-mediated lysis of dithiothreitol-treated erythrocytes involves increased C9 insertion and polymerization.
    Hu VW; Mazorow DL; Nicholson-Weller A; Shin ML
    Mol Immunol; 1987 Aug; 24(8):887-96. PubMed ID: 2821389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The killer molecule of complement.
    Müller-Eberhard HJ
    J Invest Dermatol; 1985 Jul; 85(1 Suppl):47s-52s. PubMed ID: 3891882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transmembrane channel-formation by five complement proteins.
    Müller-Eberhard HJ
    Biochem Soc Symp; 1985; 50():235-46. PubMed ID: 2428370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.